Drug profile

The FDA adverse-event record for Unknown Pain Medication

18 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Unknown Pain Medication. See the species affected, top reactions, and outcomes below.

18
adverse-event reports
33.3%
death-coded share
Dog
most-reported species
4
Seizure NOS - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
18
Total Reports
6
Deaths Reported
33.3%
Death Rate

Active Ingredients

Unknown Pain Medication

Administration Routes

UnknownOral

Species Affected

Dog 12
Cat 6

Most Affected Breeds

Retriever - Labrador 3
Siamese 2
Shepherd Dog - Australian 2
Domestic Shorthair 2
Dog (unknown) 2
Retriever - Golden 1
Domestic Mediumhair 1
Siberian Husky 1
Cat (other) 1
Deutsche Dogge, Great Dane 1

Most Reported Reactions

Seizure NOS 4
Death by euthanasia 4
Lethargy (see also Central nervous system depression in 'Neurological') 3
Anxiety 2
Vomiting 2
Lethargy (see also Central nervous system depression in Neurological) 2
Death 2
Limb weakness 2
Labelled drug-drug interaction medication error 1
Not eating 1
Haematuria 1
Limping 1

Outcome Breakdown

Outcome Unknown
5 (27.8%)
Ongoing
5 (27.8%)
Euthanized
4 (22.2%)
Recovered/Normal
2 (11.1%)
Died
2 (11.1%)

Unknown Pain Medication Adverse Event Insights

18 reports name Unknown Pain Medication; 6 recorded a death outcome (33.3% of reported events, not a population-level mortality rate). Active ingredient: Unknown Pain Medication. Administration routes: Unknown, Oral.

By species: Dog (12 reports), Cat (6 reports). By breed: Retriever - Labrador (3), Siamese (2), Shepherd Dog - Australian (2).

Leading clinical signs: Seizure NOS (4), Death by euthanasia (4), Lethargy (see also Central nervous system depression in 'Neurological') (3), Anxiety (2). Outcome, 18 coded reports: Outcome Unknown leads at 27.8%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.